209 related articles for article (PubMed ID: 31748275)
1. Contribution of proteasome-catalyzed peptide
Paes W; Leonov G; Partridge T; Chikata T; Murakoshi H; Frangou A; Brackenridge S; Nicastri A; Smith AG; Learn GH; Li Y; Parker R; Oka S; Pellegrino P; Williams I; Haynes BF; McMichael AJ; Shaw GM; Hahn BH; Takiguchi M; Ternette N; Borrow P
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24748-24759. PubMed ID: 31748275
[TBL] [Abstract][Full Text] [Related]
2. CD8(+) T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products.
Platteel AC; Mishto M; Textoris-Taube K; Keller C; Liepe J; Busch DH; Kloetzel PM; Sijts AJ
Eur J Immunol; 2016 May; 46(5):1109-18. PubMed ID: 26909514
[TBL] [Abstract][Full Text] [Related]
3. Proteasome-Generated
Mansurkhodzhaev A; Barbosa CRR; Mishto M; Liepe J
Front Immunol; 2021; 12():614276. PubMed ID: 33717099
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing.
Paes W; Leonov G; Partridge T; Nicastri A; Ternette N; Borrow P
Front Immunol; 2020; 11():563800. PubMed ID: 33072102
[TBL] [Abstract][Full Text] [Related]
5. Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and
Mishto M; Mansurkhodzhaev A; Rodriguez-Calvo T; Liepe J
Front Immunol; 2021; 12():656451. PubMed ID: 33936085
[TBL] [Abstract][Full Text] [Related]
6. A large fraction of HLA class I ligands are proteasome-generated spliced peptides.
Liepe J; Marino F; Sidney J; Jeko A; Bunting DE; Sette A; Kloetzel PM; Stumpf MP; Heck AJ; Mishto M
Science; 2016 Oct; 354(6310):354-358. PubMed ID: 27846572
[TBL] [Abstract][Full Text] [Related]
7. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
8. Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8
Platteel ACM; Liepe J; Textoris-Taube K; Keller C; Henklein P; Schalkwijk HH; Cardoso R; Kloetzel PM; Mishto M; Sijts AJAM
Cell Rep; 2017 Aug; 20(5):1242-1253. PubMed ID: 28768206
[TBL] [Abstract][Full Text] [Related]
9. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
10. Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
Peng BJ; Carlson JM; Liu MKP; Gao F; Goonetilleke N; McMichael AJ; Borrow P; Gilmour J; Heath SL; Hunter E; Bansal A; Goepfert PA
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021907
[TBL] [Abstract][Full Text] [Related]
11. Post-Translational Peptide Splicing and T Cell Responses.
Mishto M; Liepe J
Trends Immunol; 2017 Dec; 38(12):904-915. PubMed ID: 28830734
[TBL] [Abstract][Full Text] [Related]
12. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
[TBL] [Abstract][Full Text] [Related]
13. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
14. Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes.
Qin K; Boppana S; Carlson JM; Fiore-Gartland A; Files J; Zeng J; Edberg J; Mailliard RB; Ochsenbauer C; Bansal A; Goepfert P
J Virol; 2021 Jul; 95(16):e0016021. PubMed ID: 34076482
[TBL] [Abstract][Full Text] [Related]
15. Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became Infected.
Boppana S; Fiore-Gartland A; Bansal A; Goepfert P
J Virol; 2020 Jan; 94(2):. PubMed ID: 31645444
[TBL] [Abstract][Full Text] [Related]
16. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
17. Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection.
Turnbull EL; Baalwa J; Conrod KE; Wang S; Wei X; Wong M; Turner J; Pellegrino P; Williams I; Shaw GM; Borrow P
Retrovirology; 2011 Jun; 8():41. PubMed ID: 21635736
[TBL] [Abstract][Full Text] [Related]
18. Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
Chikata T; Paes W; Kuse N; Partridge T; Gatanaga H; Zhang Y; Kuroki K; Maenaka K; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2022 May; 96(10):e0043222. PubMed ID: 35475667
[TBL] [Abstract][Full Text] [Related]
19. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
[TBL] [Abstract][Full Text] [Related]
20. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
Front Immunol; 2018; 9():912. PubMed ID: 29780384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
